APY Aspyra,

Aspyra, Inc. (AMEX:APY) today announced the plans to demonstrate the latest release of AccessRAD, their RIS/PACS product at the upcoming RSNA 2008 Annual Meeting held at McCormick Place in Chicago, IL (November 30 � December 4, 2008), Booth 6610, South Building Hall A. Aspyra�s AccessRAD RIS/PACS is designed to meet the needs of acute care hospitals, enterprise-wide delivery networks, and medium to large imaging centers, with end-to-end solutions that automate processes at every point of patient and imaging encounter workflow. AccessRAD RIS/PACS release 6.4 includes enhanced productivity tools including a department management dashboard, outpatient appointment confirmation and pre-authorization verification worklists. AccessRAD RIS/PACS release�6.4�also includes an order creation feature�initiated from the�PACS when incoming diagnostic interpretation studies�are received from outside referring facilities. These orders are�automatically processed by the�RIS, thereby optimizing workflow, as well as increasing revenue by preventing lost charges due to missing or incorrect orders. Bill Culton, Aspyra�s Diagnostic Solutions Product Manager states, �As a solutions provider, we continue to enhance our products, such as AccessRAD, to provide tools and features that enable the imaging department or healthcare organization to run more efficiently, with focus on quality care, patient satisfaction and business growth.� About Aspyra Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) and Clinical Image Management Systems (CIMS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers and orthopedic environments. Aspyra's highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra, its products and services, visit www.aspyra.com. Safe Harbor Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of the date of this release, including management's own knowledge and assessment of the Company's industry, customers and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: changes in the Company�s management or other personnel, the competitive environment for Company products and services; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in the Company�s long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.